Frequently Asked Questions
The market is segmented based on , By Type (Predictive Biomarkers, Prognostic Biomarkers), Disease Indication (Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Others), Validation (Analytical Validation, Clinical Validation, Clinical Utility), End-User (Diagnostic and Research Laboratories, Hospitals Others) – Industry Trends and Forecast to 2030.
.
The Global Genomic Biomarkers Market size was valued at USD 7.59 USD Billion in 2022.
The Global Genomic Biomarkers Market is projected to grow at a CAGR of 17.5% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
